You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer

Article metrics

Article menu
Immunotherapy biomarkers
Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: November 2022 to August 2025

AbstractFullPdf
Nov 202229029666
Dec 202212112132
Jan 2023848419
Feb 2023878830
Mar 2023737337
Apr 2023336338228
May 202315715790
Jun 202313113160
Jul 202311811878
Aug 202313213467
Sep 202314214674
Oct 202315616086
Nov 202314214483
Dec 2023155156107
Jan 2024146148103
Feb 202411511777
Mar 2024223225160
Apr 2024192193123
May 202417517997
Jun 202412312686
Jul 202416817097
Aug 202411211076
Sep 202411211383
Oct 2024164165108
Nov 2024214215154
Dec 2024202206116
Jan 2025165167113
Feb 202513413683
Mar 2025174174128
Apr 2025173174130
May 2025141148107
Jun 2025797945
Jul 2025110
Aug 2025110
Total493849932943